Clinical

Dataset Information

0

NB1011 Administered by Continuous Infusion in Cancers That Overexpress Thymidylate Synthase (TS)


ABSTRACT: The purpose of this trial is to assess the tolerability and safety of NB1011 in the treatment of patients with cancers that overexpress TS, such as ovarian, gastrointestinal, colorectal, bladder, breast, and lung cancers.

DISEASE(S): Ovarian Cancer,Lung Cancer,Colorectal Cancer,Breast Cancer,Tumors

PROVIDER: 2023123 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| PRJNA847608 | ENA
| PRJNA175250 | ENA
2023-11-06 | PXD033798 | Pride
2018-05-12 | GSE114262 | GEO
| PRJNA545904 | ENA
2022-12-09 | GSE207404 | GEO
| PRJNA577129 | ENA
| PRJDB1140 | ENA
| PRJNA77739 | ENA
2013-06-01 | GSE40382 | GEO